0001144204-17-005838.txt : 20170203 0001144204-17-005838.hdr.sgml : 20170203 20170203132544 ACCESSION NUMBER: 0001144204-17-005838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170201 FILED AS OF DATE: 20170203 DATE AS OF CHANGE: 20170203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NANOVIRICIDES, INC. CENTRAL INDEX KEY: 0001379006 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 760674577 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 135 WOOD STREET STREET 2: SUITE 205 CITY: WEST HAVEN STATE: CT ZIP: 06516 BUSINESS PHONE: (203) 937-6137 MAIL ADDRESS: STREET 1: 135 WOOD STREET STREET 2: SUITE 205 CITY: WEST HAVEN STATE: CT ZIP: 06516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONIUK MILTON CENTRAL INDEX KEY: 0001580568 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36081 FILM NUMBER: 17571327 MAIL ADDRESS: STREET 1: C/O NANOVIRICIDES, INC. STREET 2: 135 WOOD STREET, SUITE 205 CITY: WEST HAVEN STATE: CT ZIP: 06516 4 1 v458347_4.xml OWNERSHIP DOCUMENT X0306 4 2017-02-01 0 0001379006 NANOVIRICIDES, INC. NNVC 0001580568 BONIUK MILTON C/O NANOVIRICIDES, INC. 1 CONTROLS DRIVE SHELTON CT 06484 1 0 0 0 Common Stock, par value $0.001 per share 2017-02-01 4 J 0 605474 0.00 D 0 I Held by Boniuk Charitable Foundation Unsecured 8% Coupon Series B Convertible Debentures 3.50 2017-02-01 4 J 0 1 0.00 D 2013-02-01 2017-01-31 Common Stock, par value $0.001 571428 0 I Held by Boniuk Charitable Foundation Effective February 1, 2017, the Reporting Person no longer holds voting and dipositive control over the shares of common stock owned by Boniuk Charitable Foundation (the "Foundation") reported in this Form 4. This Form 4 solely reflects the relinquishment of that control by the Reporting Person. The Foundation is a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. No part of the Foundation's net income may inure to the benefit of the Reporting Person or any other private person, and the assets of the Foundation may not revert to private ownership if the Foundation is dissolved. Accordingly, the Reporting Person does not and did not have a pecuniary interest in the shares held by the Foundation and such shares no longer will be reported as beneficially owned by the Reporting Person for purposes of Section 16(a). Does not include: (a) 1,240,063 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife; (b) 309,844 shares of Common Stock, 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture, or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible; or (c) 976,902 shares of Common Stock , warrants to purchase an additional 285,714 shares of Common Stock, or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; Dr. Boniuk holds voting and dispositive power over Boniuk Interests Ltd. and the Milton Boniuk IRA. Reflects the maturity date of debenture. Based upon the conversion price of $3.50. /s/ Milton Boniuk 2017-02-03